Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer
Depth and duration of response are predictive of OS in NSCLC and may aid patient management, however are not adequate surrogate endpoints for OS in clinical trials.
Authors
- Ian C. Marschner (ORCID: https://orcid.org/0000-0002-6225-1572)
- Rachel Woodford (ORCID: https://orcid.org/0000-0002-9470-314X)
- Chee Khoon Lee (ORCID: https://orcid.org/0000-0003-2955-9820)
- T. John
- J. Simes
- Sally Lord
- James Chih-Hsin Yang
Institutions
- The University of Sydney (AU)
- Peter MacCallum Cancer Centre (AU)
- National Taiwan University Hospital (TW)
- The Christie NHS Foundation Trust (GB)
- St. George Hospital (IN)
Publication Details
- Journal
- Future Oncology
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1080/14796694.2026.2630984
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00